Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.04 USD | +1.33% | +7.04% | -33.19% |
05-14 | Conduit Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-19 | Conduit Pharmaceuticals Inc. Appoints Joanne Holland as Chief Scientific Officer | CI |
Valuation
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Capitalization 1 | - | 331.3 |
Enterprise Value (EV) 1 | - | 328.1 |
P/E ratio | - | -51 x |
Yield | - | - |
Capitalization / Revenue | - | - |
EV / Revenue | - | - |
EV / EBITDA | - | - |
EV / FCF | - | - |
FCF Yield | - | - |
Price to Book | - | -735 x |
Nbr of stocks (in thousands) | - | 72,814 |
Reference price 2 | 10.25 | 4.550 |
Announcement Date | 11/07/23 | 16/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Net sales | - | - | - |
EBITDA | - | - | - |
EBIT 1 | -2.918 | -3.086 | -5.262 |
Operating Margin | - | - | - |
Earnings before Tax (EBT) 1 | -3.657 | -4.887 | -0.535 |
Net income 1 | -3.657 | -4.887 | -0.535 |
Net margin | - | - | - |
EPS | - | - | -0.0892 |
Free Cash Flow | - | - | - |
FCF margin | - | - | - |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 11/07/23 | 11/07/23 | 16/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Net Debt 1 | 0.75 | 2.01 | - |
Net Cash position 1 | - | - | 3.24 |
Leverage (Debt/EBITDA) | - | - | - |
Free Cash Flow | - | - | - |
ROE (net income / shareholders' equity) | - | 61% | 10.1% |
ROA (Net income/ Total Assets) | - | - | -91% |
Assets 1 | - | - | 0.588 |
Book Value Per Share | - | - | -0.0100 |
Cash Flow per Share | - | - | 0.0600 |
Capex | - | - | - |
Capex / Sales | - | - | - |
Announcement Date | 11/07/23 | 11/07/23 | 16/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-33.19% | 224M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- CDT Stock
- Financials Conduit Pharmaceuticals Inc.